| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 730880 | 1211530002 | ONTOZRY 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ONTOZRY 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 14 comprimidos recubiertos con película | 50 mg | 5 | 14 | 10 | 14 comprimidos recubiertos con película | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211530002/1211530002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211530002/1211530002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12744 | ANGELINI PHARMA ESPANA S.L. | 2021-06-02 | 1 | 1 | 1 | 2021-06-03 | 2021-06-02 | 1 | 2022-08-10 | View Edit Delete | ||||||||||||
| 730881 | 1211530002 | ONTOZRY 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ONTOZRY 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos recubiertos con película | 50 mg | 5 | 28 | 10 | 28 comprimidos recubiertos con película | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211530002/1211530002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211530002/1211530002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12744 | ANGELINI PHARMA ESPANA S.L. | 2021-06-02 | 1 | 1 | 1 | 2021-06-03 | 2021-06-02 | 1 | 2022-08-10 | View Edit Delete | ||||||||||||
| 766743 | 1211530002IP | ONTOZRY 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ONTOZRY 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 14 comprimidos | 50 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211530002IP/1211530002IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211530002IP/1211530002IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12744 | ABACUS MEDICINE A/S | 2025-01-23 | 1 | 1 | 1 | 2025-01-24 | 2025-01-23 | 1 | 2025-01-24 | View Edit Delete | ||||||||||||
| 730882 | 1211530005 | ONTOZRY 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ONTOZRY 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 14 comprimidos | 100 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211530005/1211530005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211530005/1211530005_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12744 | ANGELINI PHARMA ESPANA S.L. | 2021-06-02 | 1 | 1 | 1 | 2021-06-03 | 2021-06-02 | 1 | 2022-08-10 | View Edit Delete | ||||||||||||
| 730883 | 1211530005 | ONTOZRY 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ONTOZRY 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 100 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211530005/1211530005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211530005/1211530005_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12744 | ANGELINI PHARMA ESPANA S.L. | 2021-06-02 | 1 | 1 | 1 | 2021-06-03 | 2021-06-02 | 1 | 2022-08-10 | View Edit Delete | ||||||||||||
| 730884 | 1211530008 | ONTOZRY 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ONTOZRY 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 14 comprimidos | 150 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211530008/1211530008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211530008/1211530008_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12744 | ANGELINI PHARMA ESPANA S.L. | 2021-06-02 | 1 | 1 | 1 | 2021-06-03 | 2021-06-02 | 1 | 2022-08-10 | View Edit Delete | ||||||||||||
| 730885 | 1211530008 | ONTOZRY 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ONTOZRY 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 150 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211530008/1211530008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211530008/1211530008_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12744 | ANGELINI PHARMA ESPANA S.L. | 2021-06-02 | 1 | 1 | 1 | 2021-06-03 | 2021-06-02 | 1 | 2022-08-10 | View Edit Delete | ||||||||||||
| 765764 | 1211530009IP | ONTOZRY 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ONTOZRY 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 150 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211530009IP/1211530009IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211530009IP/1211530009IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12744 | ABACUS MEDICINE A/S | 2024-09-18 | 1 | 1 | 1 | 2024-09-19 | 2024-09-18 | 1 | 2024-10-22 | View Edit Delete | ||||||||||||
| 730886 | 1211530011 | ONTOZRY 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ONTOZRY 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 14 comprimidos | 200 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211530011/1211530011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211530011/1211530011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12744 | ANGELINI PHARMA ESPANA S.L. | 2021-06-02 | 1 | 1 | 1 | 2021-06-03 | 2021-06-02 | 1 | 2022-08-10 | View Edit Delete | ||||||||||||
| 730888 | 1211530011 | ONTOZRY 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ONTOZRY 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 200 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211530011/1211530011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211530011/1211530011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12744 | ANGELINI PHARMA ESPANA S.L. | 2021-06-02 | 1 | 1 | 1 | 2021-06-03 | 2021-06-02 | 1 | 2022-08-10 | View Edit Delete | ||||||||||||
| 730790 | 1211531001 | EVRYSDI 0,75 mg/ml POLVO PARA SOLUCION ORAL | EVRYSDI 0,75 mg/ml POLVO PARA SOLUCION ORAL, 1 frasco de 80 ml | 0,75 mg/ml | 6 | 80 | 26 | 1 frasco de 80 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211531001/1211531001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211531001/1211531001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 2021-04-21 | 1 | 1 | 1 | 2021-04-22 | 2021-04-21 | 1 | 2022-12-14 | View Edit Delete | ||||||||||||
| 767931 | 1211531002 | EVRYSDI 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EVRYSDI 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211531002/1211531002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211531002/1211531002_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 2025-06-11 | 1 | 1 | 1 | 2025-06-12 | 2025-06-11 | 1 | 2026-03-12 | View Edit Delete | ||||||||||||
| 730928 | 1211533001 | SEFFALAIR SPIROMAX 12,75 microgramos/100 microgramos POLVO PARA INHALACION | SEFFALAIR SPIROMAX 12,75 microgramos/100 microgramos POLVO PARA INHALACION, 1 inhalador de 60 dosis | 12,75 microgramos/100 microgramos/dosis | 86 | 60 | 30 | 1 inhalador de 60 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211533001/1211533001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211533001/1211533001_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2021-05-25 | 1 | 1 | 1 | 2021-05-26 | 2021-05-25 | 1 | 2021-10-14 | View Edit Delete | ||||||||||||
| 730997 | 1211533003 | SEFFALAIR SPIROMAX 12.75 microgramos/202 microgramos POLVO PARA INHALACION | SEFFALAIR SPIROMAX 12.75 microgramos/202 microgramos POLVO PARA INHALACION, 1 inhalador de 60 dosis | 12,75 microgramos/202 microgramos/dosis | 86 | 60 | 30 | 1 inhalador de 60 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211533003/1211533003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211533003/1211533003_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2021-05-25 | 1 | 1 | 1 | 2021-05-26 | 2021-05-25 | 1 | 2021-10-14 | View Edit Delete | ||||||||||||
| 730787 | 1211535001 | PEMAZYRE 4,5 mg COMPRIMIDOS | PEMAZYRE 4,5 mg COMPRIMIDOS, 14 comprimidos | 4,5 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211535001/1211535001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211535001/1211535001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29470 | INCYTE BIOSCIENCES IBERIA S.L. | 2021-05-07 | 1 | 1 | 1 | 2021-05-08 | 2021-05-07 | 0 | 2023-12-12 | View Edit Delete | ||||||||||||
| 730788 | 1211535003 | PEMAZYRE 9 mg COMPRIMIDOS | PEMAZYRE 9 mg COMPRIMIDOS, 14 comprimidos | 9 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211535003/1211535003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211535003/1211535003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29470 | INCYTE BIOSCIENCES IBERIA S.L. | 2021-05-07 | 1 | 1 | 1 | 2021-05-08 | 2021-05-07 | 0 | 2023-12-12 | View Edit Delete | ||||||||||||
| 730789 | 1211535005 | PEMAZYRE 13,5 mg COMPRIMIDOS | PEMAZYRE 13,5 mg COMPRIMIDOS, 14 comprimidos | 13,5 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211535005/1211535005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211535005/1211535005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 29470 | INCYTE BIOSCIENCES IBERIA S.L. | 2021-05-10 | 1 | 1 | 1 | 2021-05-11 | 2021-05-10 | 0 | 2023-12-12 | View Edit Delete | ||||||||||||
| 730836 | 1211536001 | THIOTEPA RIEMSER 15 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | THIOTEPA RIEMSER 15 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 15 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211536001/1211536001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211536001/1211536001_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38557 | ESTEVE PHARMACEUTICALS S.A. | 2021-05-10 | 1 | 1 | 1 | 2021-05-11 | 2021-05-10 | 0 | 2022-01-14 | View Edit Delete | ||||||||||||
| 730837 | 1211536002 | THIOTEPA RIEMSER 100 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | THIOTEPA RIEMSER 100 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211536002/1211536002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211536002/1211536002_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 38557 | ESTEVE PHARMACEUTICALS S.A. | 2021-05-10 | 1 | 1 | 1 | 2021-05-11 | 2021-05-10 | 0 | 2022-01-14 | View Edit Delete | ||||||||||||
| 763795 | 1211537001 | NEXPOVIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | NEXPOVIO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 8 comprimidos | 20 mg | 5 | 8 | 10 | 8 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1211537001/1211537001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211537001/1211537001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41866 | MENARINI STEMLINE ESPANA S.L. | 2023-11-28 | 1 | 1 | 1 | 2023-11-29 | 2023-11-28 | 1 | 2025-07-11 | View Edit Delete |
Page 120 of 1036, showing 20 records out of 20709 total, starting on record 2381, ending on 2400